BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2185548)

  • 1. Pathophysiology of cancer-associated hypercalcemia.
    Mundy GR
    Semin Oncol; 1990 Apr; 17(2 Suppl 5):10-5. PubMed ID: 2185548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and pathophysiology of hypercalcemia.
    Mundy GR
    Calcif Tissue Int; 1990; 46 Suppl():S3-10. PubMed ID: 2105829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of cancer-induced hypercalcemia.
    Rosol TJ; Capen CC
    Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypercalcemia and neoplasms: recent advances in pathogenesis].
    Virgolini L; Gallizia C
    Recenti Prog Med; 1990 Oct; 81(10):635-41. PubMed ID: 2291007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemic factors other than parathyroid hormone-related protein.
    Mundy GR
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):795-806. PubMed ID: 2673774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia of cancer: an update.
    Goni MH; Tolis G
    Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.
    Mosekilde L; Eriksen EF; Charles P
    Crit Rev Oncol Hematol; 1991; 11(1):1-27. PubMed ID: 1883526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
    Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
    Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia and bone resorption in malignancy.
    Walls J; Bundred N; Howell A
    Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
    Bringhurst FR; Bierer BE; Godeau F; Neyhard N; Varner V; Segre GV
    J Clin Invest; 1986 Feb; 77(2):456-64. PubMed ID: 3003159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and pathological roles of parathyroid hormone-related peptide.
    Guise TA; Mundy GR
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):307-15. PubMed ID: 8823527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathogenesis of the humoral hypercalcemia syndrome in patients with solid tumors].
    Naafs MA; Silberbusch J
    Ned Tijdschr Geneeskd; 1989 May; 133(21):1065-9. PubMed ID: 2662028
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
    Chattopadhyay N
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E761-70. PubMed ID: 16603723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
    Reagan P; Pani A; Rosner MH
    Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide mediators of hypercalcemia in malignancy.
    Strewler GJ; Nissenson RA
    Annu Rev Med; 1990; 41():35-44. PubMed ID: 2184736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1 alpha, and granulocyte colony-stimulating factor.
    Sato K; Fujii Y; Kakiuchi T; Kasono K; Imamura H; Kondo Y; Mano H; Okabe T; Asano S; Takaku F
    Cancer Res; 1989 Sep; 49(17):4740-6. PubMed ID: 2474371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.
    Seyberth HW
    Klin Wochenschr; 1978 Apr; 56(8):373-87. PubMed ID: 205705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcemia and cancer: an update.
    Murray TM; Josse RG; Heersche JN
    Can Med Assoc J; 1978 Oct; 119(8):915-20. PubMed ID: 367555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.